现货供应替西罗莫司(替西莫司)/Temsirolimus(CCI-779) C14236

产品价格: < 面议
产品型号:C14236
 牌:Chembest
公司名称:上海佰世凯化学科技有限公司
  地:上海奉贤
浏览次数:
更多
立即询价 在线咨询

产品简介

产品名称: 替西罗莫司(替西莫司) 
英文名: Temsirolimus(CCI-779) 
别名: NSC-683864;Torisel;Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate 

产品详细信息

产品名称: 替西罗莫司(替西莫司)
英文名: Temsirolimus(CCI-779)
别名: NSC-683864;Torisel;Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
化学名称: (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
CAS No. :  162635-04-3
分子式: C56H87NO16
  分子量: 1030.29
  外观: White to Off-White Solid
  溶解性: Soluble in chloroform, water, DMSO and ethano
  纯度: >99%
  Usage: Temsirolimus (also known as CCI-779) is a recently developed mTOR inhibitor;Temsirolimus has shown promising preclinical and early clinical antitumor activity and is currently in phase III clinical development for the treatment of different solid tumors, including breast cancer.

在线询价

您好,欢迎询价!我们将会尽快与您联系,谢谢!
  • *产品名称:
  • 采购数量:
  • 询价有效期:
  • *详细说明:
  •   100
  • *联系人:
  • *联系电话:
  • 附件: 附件支持RAR,JPG,PNG格式,大小在2M范围
验证码: 点击换一张
 
   温馨提示:为规避购买风险,建议您在购买前务必确认供应商资质与产品质量。

   免责申明:以上内容为注册会员自行发布,若信息的真实性、合法性存在争议,平台将会监督协助处理,欢迎举报